New Investing App Saves Investors an Average of $97,347
Most people are terrible at buying and selling stocks at the right time, but the TradeSmith app takes the emotion out of investing.

Our back test shows, the average investor would've made $97,347 more just by using the TradeSmith app analyzer software.

Check out this FREE video.
>>>

NCYT Insider Trading (Novacyt)

Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): £113,219.48
Insider Selling (Last 12 Months): GBX 0

Novacyt Insider Trading History Chart

This chart shows the insider buying and selling history at Novacyt by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Novacyt Share Price & Price History

Current Price: GBX 163
Price Change: Price Increase of +4.4 (2.77%)
As of 06/30/2022 05:35 PM ET

This chart shows the closing price history over time for NCYT up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
Tailor an Options Trading Strategy to Fit Your Needs
This guide will help you identify and execute an options trading strategy that fits your specific needs and risk profile.

Take your trading to the next level with the Options Strategy Guide.
Download your FREE Options Strategy Guide Today.

Novacyt Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/25/2022David AllmondInsiderBuy43,500GBX 231£100,485
3/18/2022Jean-Pierre CrinelliInsiderBuy3,208GBX 241£7,731.28
3/14/2022James McCarthyInsiderBuy2,360GBX 212£5,003.20
11/10/2020Edwin SnapeInsiderBuy1,080GBX 715£7,722
6/3/2020Andrew HeathInsiderBuy3,161GBX 305£9,641.05
5/15/2020James WakefieldInsiderBuy20,000GBX 305£61,000
See Full Table
Tailor an Options Trading Strategy to Fit Your Needs
This guide will help you identify and execute an options trading strategy that fits your specific needs and risk profile.

Take your trading to the next level with the Options Strategy Guide.
Download your FREE Options Strategy Guide Today.

SEC Filings (Institutional Ownership Changes) for Novacyt (LON:NCYT)

Novacyt logo
Novacyt S.A., together with its subsidiaries, engages in the development, manufacture, contract design, and commercialization of diagnostic products for cancer and infectious diseases in the United Kingdom, rest of Europe, the United States, the Asia Pacific, the Middle East, and Africa. It operates through Primer Design, Lab21 Products, and IT-IS International. The Primer Design segment designs, manufactures, and markets molecular real-time qPCR testing devices and reagents in the areas of infectious diseases. The Lab21 Products segment develops, manufactures, and distributes a range of protein-based infectious disease in-vitro diagnostic device (IVD) products. The IT-IS International segment develops and manufactures PCR devices for the life sciences and food testing industry. It serves hospitals and corporates. The company was incorporated in 2006 and is based in Vélizy-Villacoublay, France.
Read More on Novacyt

Today's Range

Now: GBX 163
Low: 151.30
High: 163

50 Day Range

MA: GBX 154.16
Low: 133.40
High: 199.90

52 Week Range

Now: GBX 163
Low: 131.18
High: 497.30

Volume

247,150 shs

Average Volume

379,789 shs

Market Capitalization

£115.12 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Novacyt?

Novacyt's top insider shareholders include:
  1. David Allmond (Insider)
  2. Edwin Snape (Insider)
  3. James McCarthy (Insider)
  4. Jean-Pierre Crinelli (Insider)
Learn More about top insider investors at Novacyt.
New Investing App Saves Investors an Average of $97,347
Most people are terrible at buying and selling stocks at the right time, but the TradeSmith app takes the emotion out of investing.

Our back test shows, the average investor would've made $97,347 more just by using the TradeSmith app analyzer software.

Check out this FREE video.
>>>